According to a recent Apollo News report, China is the world’s largest manufacturer of fever medication. About 50% of the global supply of paracetamol and ibuprofen comes from the country.

Since the easing of the stringent “zero-COVID” policy following nationwide protests, China has shown signs of running out of these drugs.

Apollo pointed out several different factors that have led to China’s current severe supply shortage.

First, Chinese health authorities under the ruling of the CCP have not yet developed the habit of planning ahead, evaluating current production capacity and market demand to ensure sufficient drug supplies for the nation, let alone creating a contingency plan.

Instead, they normally just stand aside and let the market regulate itself.

Apollo noted that Chinese health regulators held a press conference on December 7 to address issues related to COVID pandemic control measures.

At the meeting, Guo Yanhong, director of the health emergency division at China National Health Commission, did not mention anything about the need to increase production capacity or the insufficient supply of these medicines.

Instead, Guo said that there will be enough medicine for everyone in either pharmacies or hospitals, so there’s no need to hoard and rush to buy these in advance.

Second reason is domestic manufacturers received the CCP’s orders to start mass production at the last minute, so there was obviously not enough time to prepare and complete the order.

A leading supplier of fever medication in China revealed that it did not think about increasing production output until the CCP suddenly released 10 new measures for COVID control.

The company further explained that due to the flu season in the winter time, it is often already proactive in producing more medicine than usual. But the new order this time came so abruptly and really put it in a very difficult situation.

There is no way to “produce antipyretics [fever medication] as soon as possible” as the CCP wants, as the process needs some time from the start to finish and then distribute products to pharmacies.

A Chinese netizen also thought this was kind of funny as the orders reached the manufacturers and netizens almost at the same time.

Last but not least is that in China, everything must be done on Chinese leaders’ orders. Therefore, whether anyone realizes the urgency to do something for the country, they still need to wait for the orders. And when the orders come, it’s often already too late, and that’s what has led China to the current dilemma today.

As reported by Apollo, China is facing a very serious shortage of medication.

Earlier last week, the Chinese Ministry of Industry and Information Technology had to send out letters calling for assistance in the production of Lianhua Qingwen capsules for influenza. 

As reported by Forbes, Chinese authorities have been promoting the herbal remedy for reducing symptoms such as fever and sore throat in mild COVID cases. As a result, Shijiazhuang Yiling shares had almost quadrupled since the pandemic first started in 2020.

However, a Chinese healthcare platform named Dingxiang Yisheng has published an article saying that there is no official evidence to prove the efficacy of Lianhua Qingwen in preventing the coronavirus.

The report also said that the World Health Organization has not yet approved the capsules for treating COVID. 

In addition, the supply scarcity also prompted Chinese state-owned Sinopharm to sign an agreement on December 15 to purchase and distribute in China Paxlovid, Pfizer’s latest COVID-19 pill.

Regarding the severe shortage of fever medication in China, China News reported that Chinese citizens have to buy the medicines from their friends and relatives living overseas.

This is because in China, retailers sell these products at prices way higher than those abroad.

Let’s take Doliprane as an example. In France, this drug costs only $2.30 (16 yuan) per box. But in China, JD.com sells it for as high as $23 (160 yuan), which is ten times more expensive.

No one knows where that leaves citizens looking for medication.

Sign up to receive our latest news!

By submitting this form, I agree to the terms.